The JNK/c-Jun cascade and Alzheimer's disease.
Emerging evidence indicates that the JNK/c-Jun cascade is activated in neurons of the Alzheimer's disease brain and suggests its involvement in abnormal processes, ranging from tau phosphorylation to neuronal death. Substantial new data have accumulated on the functional relevance of causative genes in familial Alzheimer's disease and the pathological processes that occur within neurons. In this review, we summarize reported findings of the JNK/c-Jun cascade in Alzheimer's disease and discuss the relationship between the cascade and other pathological processes. We suggest that the effort to connect amyloid deposition with intracellular activation of the JNK/c-Jun cascade may modify the amyloid theory of Alzheimer's disease. Therapeutic approaches targeting the JNK/c-Jun cascade and other signaling may complement therapeutic strategies directed at reducing amyloid deposition.
Okazawa
Hitohi
H
Department of Neurology, Graduate School of Medicine, University of Tokyo, Japan.
Estus
Steven
S
D000544:Alzheimer Disease / Q000235:genetics* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000686:Amyloidosis / Q000235:genetics* / Q000473:pathology; D000818:Animals; D001921:Brain / Q000473:pathology; D016923:Cell Death / Q000235:genetics; D015971:Gene Expression Regulation, Enzymologic / Q000502:physiology; D016758:Genes, jun / Q000235:genetics*; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics*; D009474:Neurons / Q000473:pathology
D016229:Amyloid beta-Peptides; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases